Upgrade to SI Premium - Free Trial

Barclays Downgrades Novartis (NVS) to Underweight

October 25, 2017 1:39 AM
Barclays downgraded Novartis (NYSE: NVS) from Equalweight to Underweight.Analyst Emmanuel Papadakis believes the underlying ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades Hot Downgrades

Next Articles